-
MG-132 (Z-LLL-al): Proteasome Inhibitor Guide
2026-09-15
MG-132, also called Z-LLL-al, is a membrane-permeable peptide aldehyde used to inhibit proteasomal protein degradation. It supports apoptosis assay, cell cycle arrest studies, cancer research, and oxidative stress and ROS generation workflows, but cellular potency and selectivity depend strongly on assay context.
-
Cyanine 3 Tyramide: Reliable Signal Amplification
2026-09-15
This scenario-driven guide explains how Cyanine 3 Tyramide (SKU K1085) can strengthen low-abundance molecular readouts associated with viability, proliferation, and cytotoxicity studies without being mistaken for a direct viability reagent. It covers TSA compatibility, preparation, controls, interpretation, storage, and practical vendor-selection criteria.
-
Partial BACE1 Inhibition and Synaptic Transmission
2026-09-14
Satir et al. show that moderate BACE inhibition can reduce amyloid-beta secretion by up to 50% in primary cortical neurons without measurably impairing synaptic transmission. The study defines a concentration-dependent safety window that helps interpret BACE1-targeted approaches in Alzheimer’s disease research, while also showing that stronger inhibition can disrupt neuronal signaling.
-
Hydroxytyrosol Workflows for Cardiovascular Research
2026-09-14
Build reproducible Hydroxytyrosol assays around oxidative stress, macrophage inflammation, and cholesterol efflux rather than relying on a single antioxidant readout. This workflow translates comparative olive oil polyphenol findings into practical dose design, controls, and troubleshooting for cardiovascular health research.
-
Nonivamide: A TRPV1 Assay-to-Mechanism Guide
2026-09-13
Nonivamide is a capsaicin analog that connects TRPV1 activation with cancer cell growth inhibition and sensory-neuron biology. This guide translates the evidence into practical assay decisions for glioma research, small cell lung cancer models, and context-dependent TRPV1 studies.
-
Mildronate-Derived Lipidoids for Safer mRNA Vaccines
2026-09-12
A 2024 ACS Nano study developed mildronate-derived cationic lipids that enabled effective mRNA delivery at a low lipid dose while reducing local inflammation relative to an SM102-based comparator. In prophylactic and therapeutic B16OVA melanoma models, the resulting mLNP-69 formulation supported vaccine activity, providing a preclinical framework for balancing expression, immune activation, and tolerability.
-
Cy5 TSA Fluorescence System Kit for Tissue Repair Studies
2026-09-11
The Cy5 TSA Fluorescence System Kit helps resolve weak spatial signals in intestinal inflammation models, from CCDC25 and IL-22 immunostaining to transcript detection by FISH. Its HRP-dependent, covalent Cy5 deposition can improve sensitivity while conserving scarce antibodies and preserving tissue-level localization.
-
TAK-715: Practical p38 MAPK Inhibitor Workflows
2026-09-11
TAK-715 is a potent, p38α-focused research reagent for connecting kinase activity with cytokine output in cell-based inflammation models. Its nanomolar potency, distinct inhibitory profile, and suitability for mechanistic dephosphorylation assays make it useful for both routine pathway inhibition and advanced rheumatoid arthritis research.
-
2-Thio-dCTP Workflows for Precision DNA Studies
2026-09-10
2-Thio-dCTP enables controlled tests of DNA polymerase selectivity, site-specific DNA modification, and DNA–protein interactions rather than serving as a one-size-fits-all replacement for dCTP. This practical guide connects those established biochemical uses with the emerging SCP4–H3T3 chromosome-stability pathway while separating validated workflows from exploratory applications.
-
Candida krusei Phase-Specific Apoptosis in BMECs
2026-09-10
The reference study shows that Candida krusei yeast and hypha phases trigger bovine mammary epithelial-cell apoptosis through different signaling routes. Yeast cells preferentially engage mitochondrial injury, whereas hyphae more strongly involve death ligand/receptor signaling, with TLR2/ERK and JNK/ERK pathways contributing to both responses.
-
BIIE 0246: Mapping Y2R in Neurocardiac Models
2026-09-09
BIIE 0246 is a selective neuropeptide Y Y2 receptor antagonist for separating Y2R-dependent signaling from the Y1R mechanism implicated in adipose-neural cardiac arrhythmia. This article translates the key findings of Fan et al. into practical assay-selection, control, and interpretation strategies.
-
LL-37 Fragments Against MDR Acinetobacter Biofilms
2026-09-09
The reference study evaluates human cathelicidin LL-37 and three truncated fragments against multidrug-resistant Acinetobacter baumannii, combining planktonic killing, anti-adherence, biofilm inhibition, and biofilm dispersal assays. Its main contribution is showing that selected fragments, particularly KS-30 and KR-20, can retain clinically relevant antimicrobial activity while also targeting biofilm-associated phenotypes.
-
Nonivamide for TRPV1 and Cancer Research
2026-09-08
Nonivamide is a capsaicin analog that enables paired TRPV1 calcium-signaling and cancer cell growth inhibition studies. This guide translates receptor pharmacology, apoptosis assays, glioma research, small cell lung cancer models, and sensory-neuron findings into practical workflows with formulation and troubleshooting guidance.
-
Cy5 TSA Fluorescence System Kit Workflow
2026-09-08
The Cy5 TSA Fluorescence System Kit converts localized HRP activity into a bright, far-red signal for difficult IHC, ICC, and FISH targets. This guide connects atlas-informed experimental design with practical deposition parameters, quantitative controls, and troubleshooting for reliable detection of low-abundance targets.
-
Stattic: A Causal Probe of STAT3 Across Cell Contexts
2026-09-07
STAT3 is a convergence point linking cellular stress, survival, vascular remodeling, and treatment resistance. This thought-leadership guide examines how Stattic can move translational research beyond pathway description by connecting STAT3 mechanism to experimental causality, HNSCC radiosensitization, apoptosis, and emerging lymphatic biology.